Trial of Autologous, Hapten-Modified Vaccine, OVAX, in Patients With Relapsed Stage III or IV Ovarian Cancer
Sponsors and Collaborators
ContactUnited States, Illinois
Julio D Doligosa
847-872-4019 [email protected]
United States, Oklahoma
Sharrese Bishop, RN,BSN,CCRC
United States, Pennsylvania
Marty Weinar, MS, RN, CAGS
Henry E Schea
Next post in Ovarian Cancer Clinical Trials
Want to view more content from Cancer Therapy Advisor?
Register now at no charge to access unlimited clinical news, full-length features, case studies, conference coverage, and more.
Want to read more?
Please login or register first to view this content.